Study AZ3110866, a Fixed Dose Study of SB-742457 Versus Placebo When Added to Existing Donepezil Treatment in Subjects With Mild-to-Moderate Alzheimer's Disease.
Phase of Trial: Phase II
Latest Information Update: 24 May 2017
At a glance
- Drugs Intepirdine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 24 May 2017 Results of a cost analysis presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 28 Apr 2017 Results presented at the 69th Annual Meeting of the American Academy of Neurology.
- 09 Dec 2016 According to an Axovant Sciences media release, new analysis of this was presented in an oral session at the 2016 Clinical Trials in Alzheimer's Disease (CTAD) Meeting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History